메뉴 건너뛰기




Volumn 5, Issue 4, 2004, Pages 291-304

Novel inhibitors of HIV-1 integration

Author keywords

Diketo acids; HIV; Inhibitors; Integrase; LEDGF; Pyranodipyrimidines; Resistance

Indexed keywords

1 (5 CHLOROINDOL 3 YL) 3 HYDROXY 3 (2H TETRAZOL 5 YL)PROPENONE; 1 [5 (4 FLUOROBENZYL) 2 FURYL] 3 (1,2,4 TRIAZOL 3 YL) 1,3 PROPANEDIONE; 4 [1 (4 FLUOROBENZYL) 2 PYRROLYL] 2,4 DIOXOBUTYRIC ACID; ANTIRETROVIRUS AGENT; CAFFEIC ACID PHENETHYL ESTER; CICHORIC ACID; CYNARINE; GLYCOPROTEIN GP 120; GRANULATINE; HYDRAZIDE DERIVATIVE; INTEGRASE; INTEGRASE INHIBITOR; INTEGRIC ACID; L 708906; N (4 FLUOROBENZYL) 8 HYDROXY 5 (TETRAHYDRO 2H 1,2 THIAZIN 2 YL) 1,6 NAPHTHYRIDINE 7 CARBOXAMIDE S,S DIOXIDE; NAPTHTOTHIAZEPINE; OXOACID; PROTEINASE; PROTEINASE INHIBITOR; PYRIMIDINE DERIVATIVE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; SALICYLHYDRAZIDE; THIAZEPINE DERIVATIVE; UNCLASSIFIED DRUG; V 165; VIRUS DNA; VIRUS ENVELOPE PROTEIN;

EID: 3242886580     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389200043335487     Document Type: Review
Times cited : (51)

References (95)
  • 1
  • 48
    • 3242887553 scopus 로고    scopus 로고
    • Multiple mutations in human immunodeficiency Virus-1 integrase confer resistance to the phase I/II clinical trial drug S-1360
    • Submitted for publication
    • Fikkert, V., Van Remoortel, B., Pannecouque, C., De Maeyer, M., De Clercq, E., Debyser, z. and Witvrouw, M. Multiple mutations in human immunodeficiency Virus-1 integrase confer resistance to the phase I/II clinical trial drug S-1360. AIDS, Submitted for publication.
    • AIDS
    • Fikkert, V.1    Van Remoortel, B.2    Pannecouque, C.3    De Maeyer, M.4    De Clercq, E.5    Debyser, Z.6    Witvrouw, M.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.